CANDACE LEWIS: Open Payments
NPI 1912319781 · LOCUST GROVE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,672 in 86 payments from 22 companies in 2025. Trend: 2023 $1,488 · 2024 $1,346 · 2025 $1,672
Food & beverage: $1,672
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $291 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $154 |
| Lilly USA, LLC | 8 | $132 |
| PFIZER INC. | 7 | $130 |
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| GlaxoSmithKline, LLC. | 7 | $123 |
| Novo Nordisk Inc | 6 | $117 |
| Otsuka America Pharmaceutical, Inc. | 5 | $110 |
| Corcept Therapeutics | 3 | $82 |
| ABBVIE INC. | 4 | $81 |
Products named: Kerendia, AIRSUPRA, AMVUTTRA, FARXIGA, REXULTI, NURTEC ODT, MOUNJARO, Korlym.
Industry payments across GA — which companies pay providers there.
